Early versus delayed surgery following neoadjuvant chemoradiation for esophageal cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Early versus delayed surgery following neoadjuvant chemoradiation for esophageal cancer: a systematic review and meta-analysis

Published:2023-02-17 Issue:3 Volume:20 Page:390-401
ISSN:1612-9059
Container-title:Esophagus
language:en
Short-container-title:Esophagus

Author:

Karthyarth Mithun Nariampalli,Mathew Anvin^ORCID,Ramachandra Deepti,Goyal Anuj,Yadav Neeraj Kumar,Reddy Kamireddy Madana Raghava,Rakesh Nirjhar Raj,Kaushal Gourav,Dhar Puneet

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

https://link.springer.com/content/pdf/10.1007/s10388-023-00989-y.pdf

Reference45 articles.

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

2. Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, et al. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomized controlled trial. Lancet Oncol. 2015;16(9):1090–8.

3. Nilsson K, Klevebro F, Rouvelas I, Lindblad M, Szabo E, Halldestam I, et al. Surgical morbidity and mortality from the multicenter randomized controlled NeoRes II trial: standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for esophageal cancer. Ann Surg. 2020;272(5):684–9.

4. Ruol A, Rizzetto C, Castoro C, Cagol M, Alfieri R, Zanchettin G, et al. Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome? Ann Surg. 2010;252(5):788–96.

5. Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, et al. Verification of the optimal interval before esophagectomy after preoperative neoadjuvant chemoradiotherapy for locally advanced thoracic esophageal cancer. Ann Surg Oncol. 2021;28(4):2101–10.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma?;Journal of Cancer Research and Clinical Oncology;2024-03-27

2. Inhibition of Apoc1 reverses resistance of sorafenib by promoting ferroptosis in esophageal cancers;Gene;2024-01

3. Standard versus prolonged intervals to surgery in resectable esophageal cancer: does timing matter?;Annals of Oncology;2023-11